Table 2.
Equivalent tissue dose calculation parameters
| Tissue/organ | Tissue weighting factora | Estimated fraction irradiatedb | OSL ID number(s) |
| Bone marrow | 0.120 | 16.5% | |
| Mandible | 1.3% | 12, 14, 16, 20 | |
| Calvarium | 11.8% | 1, 3, 4 | |
| Cervical spine | 3.4% | 15 | |
| Thyroid | 0.040 | 100.0% | 23, 24 |
| Oesophagus | 0.040 | 10.0% | 25 |
| Skin | 0.010 | 5.0% | 6, 8, 10, 22 |
| Bone surface | 0.010 | 16.5% | |
| Mandible | 1.3% | 12, 14, 16, 20 | |
| Calvarium | 11.8% | 1, 3, 4 | |
| Cervical spine | 3.4% | 15 | |
| Salivary glands | 0.010 | 100.0% | |
| Parotid | 100.0% | 11, 13 | |
| Submandibular | 100.0% | 17, 21 | |
| Sublingual | 100.0% | 18, 19 | |
| Remainder | 0.009 eachc | ||
| Lymphatic nodes | 5.0% | 11–21, 24, 25 | |
| Muscle | 5.0% | 11–21, 24, 25 | |
| Extrathoracic airway | 100.0% | 7, 9, 11–21, 24, 25 | |
| Oral mucosa | 100.0% | 11–14, 16–21 |
ID, identification; OSL, optically stimulated luminescence.
Based on 2007 International Commission on Radiological Protection recommendations.
Based on the work by Ludlow et al9.
Remainder tissue/organs tissue weighting factor 0.12 total, divided by 13 possible tissues/organs.